PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Sep 30, 2026, 5:09 PM

Leading CDMO to attend CPHI Milan 2026 in Italy

<p><!-- wp:paragraph --></p>

Pharma Tech

Sep 30, 2026, 4:40 PM

EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis

Data arrives as drugmakers race to bring successors to popular obesity therapies like semaglutide and tirzepatide to market.

Pharma Tech

Sep 30, 2026, 4:18 PM

Atossa plans shareholder stake in potential PRV proceeds

Shareholders could be set for a cash reward if the biotech wins a voucher upon approval of (Z)-endoxifen.

ET Pharma

Sep 30, 2026, 12:42 PM

Sanofi India served ₹16.4 crore tax notice over discrepancies in GST filing

In an intimation to the stock exchange, Sanofi said the notice alleges several discrepancies between the value of supplies reported in e-way bills and the corresponding disclosures, reported turnover and input tax claims made by the company for FY 2022-23.

PharmaShots

Sep 30, 2026, 12:29 PM

Meitheal Pharmaceuticals Reports US FDA Approval of High-Concentration Formulation of Yusimry (Biosimilar, Humira)

Shots Ref: Businesswire  |   Image: Meitheal Pharmaceuticals  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Meitheal Pharmaceuticals Reports US FDA Approval of High-Concentration Formulation of Yusimry (Biosimilar, Humira) appeared first on PharmaShots.

Express Pharma

Sep 30, 2026, 12:02 PM

Biodeal Pharmaceuticals acquires Biological E facility, expands into sterile injectables

The manufacturing facility adds 135 million-unit annual capacity, with Carbapenem line now operational and validated under Biodeal’s ownership The post Biodeal Pharmaceuticals acquires Biological E facility, expands into sterile injectables appeared first on Express Pharma.

News

Latest industry coverage

Google News

Sep 30, 2026, 9:29 PM

Q&A: How One Pharmaceutical Manufacturer Is Implementing AI - Automation World

Q&A: How One Pharmaceutical Manufacturer Is Implementing AI  Automation World

Google News

Sep 30, 2026, 9:02 PM

Merck’s Conrod Kelly on leaning into cultural moments in pharma - Medical Marketing and Media

Merck’s Conrod Kelly on leaning into cultural moments in pharma  Medical Marketing and Media

Google News

Sep 30, 2026, 8:35 PM

A new CEO will lead the supplier of 350+ ingredients used in medicines. - Stock Titan

A new CEO will lead the supplier of 350+ ingredients used in medicines.  Stock Titan

Google News

Sep 30, 2026, 8:32 PM

TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness - GlobeNewswire

TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness  GlobeNewswire

Google News

Sep 30, 2026, 8:21 PM

Atmospheric Pressure Ionization Modules Market Forecast to 2035: Growth Driven by Rising Demand for Mass Spectrometry in Pharmaceutical R&D - IndexBox

Atmospheric Pressure Ionization Modules Market Forecast to 2035: Growth Driven by Rising Demand for Mass Spectrometry in Pharmaceutical R&D  IndexBox

Google News

Sep 30, 2026, 8:21 PM

Trump Finalizes Drug Pricing Model for Most-Favored-Nation Plan - Bloomberg Law News

Trump Finalizes Drug Pricing Model for Most-Favored-Nation Plan  Bloomberg Law News

Google News

Sep 30, 2026, 8:14 PM

Taiho Oncology and Taiho Pharmaceutical Announce Positive Topline Results in Phase 3 AZTOUND Trial Evaluating Oral Azacitidine and Cedazuridine in Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia - Business Wire

Taiho Oncology and Taiho Pharmaceutical Announce Positive Topline Results in Phase 3 AZTOUND Trial Evaluating Oral Azacitidine and Cedazuridine in Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia  Business Wire

Google News

Sep 30, 2026, 8:09 PM

Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity Drug - Investor's Business Daily

Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity Drug  Investor's Business Daily

Google News

Sep 30, 2026, 8:05 PM

Halozyme Announces Appointment of Jim Daly to its Board of Directors - PR Newswire

Halozyme Announces Appointment of Jim Daly to its Board of Directors  PR Newswire

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer